The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials

被引:20
作者
Gruner, Laura F. [1 ,2 ]
Amitay, Efrat L. [1 ]
Heisser, Thomas [1 ,2 ]
Guo, Feng [1 ]
Niedermaier, Tobias [1 ]
Gies, Anton [3 ,4 ]
Hoffmeister, Michael [1 ]
Brenner, Hermann [1 ,3 ,4 ,5 ]
机构
[1] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Med Fac Heidelberg, D-69120 Heidelberg, Germany
[3] German Canc Res Ctr, Div Prevent Oncol, D-69120 Heidelberg, Germany
[4] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany
[5] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany
关键词
colorectal cancer; early detection; screening; fecal occult blood tests; invitation; IMMUNOCHEMICAL TESTS; INCREASING PARTICIPATION; POPULATION; PROGRAM; IMPLEMENTATION; INTERVENTIONS; STRATEGIES; ADHERENCE; OUTREACH; LEAFLET;
D O I
10.3390/cancers13071520
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary There is large heterogeneity in invitation schemes and participation rates in colorectal cancer screening programs offering fecal occult blood tests (nowadays mostly fecal immunochemical tests). It is unclear what the most effective invitation strategies are for fecal occult blood tests. In this systematic review, advance notification, mailed fecal occult blood test, and reminders had major, consistent, and complementary potential to increase participation in fecal occult blood test-based colorectal cancer screening. Our findings show that the effectiveness of invitations for fecal occult blood test-based colorectal cancer screening can be substantially increased across several settings by the implementation of comprehensive invitation strategies. Personal invitations for fecal occult blood tests (nowadays mostly fecal immunochemical tests) are increasingly used to raise their usage for colorectal cancer screening. However, there is a large heterogeneity in applied invitation schemes. We aimed to review evidence for the effectiveness of various invitation schemes. The main outcome was the fecal occult blood test usage rate. A systematic search was performed in Medline and Web of Science (up to 9 July 2020). Randomized controlled trials or cluster-randomized controlled trials were eligible, which reported on general invitations for fecal occult blood test-based colorectal cancer screening sent to the general population at average colorectal cancer risk. (PROSPERO 2020 CRD42020169409). Overall, 34 studies were included. Invitations with an attached, i.e., mailed fecal occult blood test consistently increased test usage by 4-19.7% points, compared to other methods of test provision. Likewise, the introduction of advance notification consistently led to a higher usage rate, with an increase of 3.3-10.8% points. Reminders showed positive but varying effects by method. With an increase of 8.5-15.8% points, letter or email reminders were more effective than reminders by phone call or text message (0.6-6.5% points). Inconsistent results were found for financial incentives ((-8.4)-20% points) and for added or changed invitation material ((-3.5)-11.8% points). With 3.5-24.7% points, the strongest increases in use were achieved by multifaceted invitation, implementing multiple components. Any invitation scheme was superior over no invitation. Advance notification, mailing of fecal occult blood test, and reminders were consistently shown to have major, complementary potential to increase participation in fecal occult blood test-based colorectal cancer screening settings.
引用
收藏
页数:14
相关论文
共 60 条
[1]   Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting [J].
Akram, Ali ;
Juang, Derek ;
Bustamante, Ranier ;
Liu, Lin ;
Earles, Ashley ;
Ho, Samuel B. ;
Wang-Rodriguez, Jessica ;
Allison, James E. ;
Gupta, Samir .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (08) :1265-+
[2]   Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial [J].
Barthe, Juliette ;
Perrodeau, Elodie ;
Gilberg, Serge ;
Ravaud, Philippe ;
Ghasarossian, Christian ;
Marchand-Buttin, Franoise ;
Deyra, Jacques ;
Falcoff, Hector .
AMERICAN JOURNAL OF MEDICINE, 2015, 128 (09) :1024.e1-1024.e7
[3]   Status of implementation and organization of cancer screening in The European Union Member StatesSummary results from the second European screening report [J].
Basu, Partha ;
Ponti, Antonio ;
Anttila, Ahti ;
Ronco, Guglielmo ;
Senore, Carlo ;
Vale, Diama Bhadra ;
Segnan, Nereo ;
Tomatis, Mariano ;
Soerjomataram, Isabelle ;
Zakelj, Maja Primic ;
Dillner, Joakim ;
Elfstrom, Klara Miriam ;
Lonnberg, Stefan ;
Sankaranarayanan, Rengaswamy .
INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (01) :44-56
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]   Comparative Effectiveness of Mailed Reminders With and Without Fecal Immunochemical Tests for Medicaid Beneficiaries at a Large County Health Department: A Randomized Controlled Trial [J].
Brenner, Alison T. ;
Rhode, Jewels ;
Yang, Jeff Y. ;
Baker, Dana ;
Drechsel, Rebecca ;
Plescia, Marcus ;
Reuland, Daniel S. ;
Wroth, Tom ;
Wheeler, Stephanie B. .
CANCER, 2018, 124 (16) :3346-3354
[6]   Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies [J].
Brenner, Hermann ;
Stock, Christian ;
Hoffmeister, Michael .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
[7]   Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy [J].
Brenner, Hermann ;
Tao, Sha .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) :3049-3054
[8]   Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study [J].
Buskermolen, Maaike ;
Cenin, Dayna R. ;
Helsingen, Lise M. ;
Guyatt, Gordon ;
Vandvik, Per Olav ;
Haug, Ulrike ;
Bretthauer, Michael ;
Lansdorp-Vogelaar, Iris .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
[9]   Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey [J].
Cardoso, Rafael ;
Guo, Feng ;
Heisser, Thomas ;
Hoffmeister, Michael ;
Brenner, Hermann .
CANCERS, 2020, 12 (06)
[10]   An advance notification letter increases participation in colorectal cancer screening [J].
Cole, S. R. ;
Smith, A. ;
Wilson, C. ;
Turnbull, D. ;
Esterman, A. ;
Young, G. P. .
JOURNAL OF MEDICAL SCREENING, 2007, 14 (02) :73-75